Skip to content

Leading cancer congress coming to Copenhagen

06.09.2016  10:12
Cancer treatment and care will bring nearly 20 000 delegates to Copenhagen from 7 to 11 October 2016, for the largest and most important oncology congress in Europe.


Delegates (including medical and clinical oncologists, pathologists, researchers, patient advocates, pharmaceutical companies and representatives from international media) will come together from many disciplines and countries, to focus on finding the most effective cancer treatment solutions available today. Studies presented at ESMO 2016 will have a direct impact on the treatment and care of cancer patients worldwide.

Cancer is a feared diagnosis. Over 3.45 million people are diagnosed with cancer every year in Europe (14.1 million worldwide). In 2012, there were 1.75 million deaths from cancer in Europe, where the disease is becoming the main cause of death. This represents a huge burden on health systems and the economy. The innovative science presented at the ESMO Congress will bring good news for physicians, patients and policy makers alike.  Oncology is a rapidly developing speciality and research in the field is allowing more and more patients to be cured or to live longer and better with the disease.

“From disease treatment to patient care” is the 2016 ESMO Congress motto this year. It reflects ESMO’s dedication – across disciplines and across cultures- to ensure that cancer patients receive individually tailored care: from diagnosis, to timely and equal access to the best treatment, to the best overall care.

Denmark recently launched an ambitious new Cancer Plan (1) that aims to ensure more people survive cancer and live better lives after treatment. It includes new smoking restrictions and a big investment (2.2 billion kroner) in order to improve Denmark’s survival rate for cancer patients, which is among the lowest in Europe. The plan includes a “patient first” strategy emphasizing that treatment should be tailored to each patient, and that patients themselves should be an active part of the health care system.

Over 1,600 studies, presented by researchers coming from all over the world, will be discussed at the ESMO Congress. They represent innovative ways to treat cancer and new hope for patients. ESMO also includes a Patient Advocacy Track where topics such as the importance of patients driving research will be highlighted.

ESMO 2016 has an extensive press programme where breaking news will be announced regarding treatments that will change the practice of oncology. These trial results are under embargo until the Congress.

To brief media on news opportunities at ESMO Congress, Dr. Stefan Zimmermann from University Hospital in Lausanne, Switzerland, member of the ESMO Press Committee, will speak at a media event at IPC in Copenhagen on Thursday 15 September. He will highlight hot topics to keep an eye on during the congress, as well as explain the ESMO press programme and possibilities for individual interviews.

Prof Ulrik Lassen, Chief Physician at the Centre for Oncology Denmark who is ESMO National Representative in Denmark as well as Local Officer for the ESMO 2016 Congress, will also speak at the press conference presenting the Danish oncology research landscape. He will be available to answer questions.

The briefing takes place on Thursday 15 September from 14.30-15.15 PM at:
IPC, The International Press Centre
Skindergade 7
1159 Copenhagen

To sign-up for the press briefing, please e-mail:
Peter Krause, Head of International Press Centre

For any further information please contact:
Henriette Tybjerg, Advisor at Hansen agenda / direct phone: 00 45 26 79 39 81

- - - - - -


Europe’s leading oncology congress will be held in Copenhagen from 7 to 11 October 2016 at the Bella Center congress venue

This fall Copenhagen will host Europe’s leading oncology congress, ESMO 2016, where the latest cutting-edge and practice-changing oncology research will be presented. ESMO has had a 71% increase in submissions of abstracts for the 2016 meeting, as scientists and experts from all over the world seek the ESMO Congress as a platform to present their latest research.

ESMO is an annual meeting held in different European countries each year.  This year with almost 20.000 delegates from all over the world and 50  late breaking trials being accepted for presentation, the congress hopes to be the focus of the Danish and international oncology community.

The ESMO congress, which takes an integrated approach to oncology, attracts an international community of experts across a wide range of disciplines all of whom share the common goals of finding the most effective cancer treatments and of making them equally available to patients everywhere. “From disease treatment to patient care” is the motto of this year’s ESMO congress, a topic close to the Danish experience, as shown by the recently launched national Cancer Plan which aims to improve cancer care and survival in Denmark.

Don’t miss out on the opportunity to attend the ESMO 2016 Congress, which take place at the Bella Center in Copenhagen from the 7th to the 11th of October this year.

Ulrik Lassen, Rigshospitalet
Søren Brunak, The Novo Nordisk Foundation

Gedske Daugaard, Rigshospitalet

Jørn Herrstedt, Odense University Hospital

Karen-Lise Spindler, Aarhus University Hospital
Mogens Vyberg, Aalborg University Hospital

Roger Stupp, University of Zurich, Switzerland
Eric Van Cutsem, University Hospital Leuven, Belgium
Johann de Bono, Royal Marsden Hospital, United Kingdom
Jonathan Ledermann, UCL Cancer Institute, University College London, United Kingdom
Jean Bourhis, Institut Gustave Roussy, Paris, France
Jim Allison, MD Anderson Cancer Center, Texas, United States
Caroline Robert, Institut Gustave Roussy, Paris, France
Jean-Charles Soria, Institut Gustave Roussy, Paris, France
Paolo Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Martine Piccart, Université Libre de Bruxelles, Belgium 

Find the full congress programme here:

Read more about the congress at the official ESMO site:

Read more about how register as media here: